An approved drug normally used to treat fungal infections could also do the job of a protein channel that is missing or dysfunctional in the lungs of people with cystic fibrosis, operating as a prosthesis on the molecular scale, says new research.
from All Top News -- ScienceDaily https://www.sciencedaily.com/releases/2019/03/190313143248.htm
from All Top News -- ScienceDaily https://www.sciencedaily.com/releases/2019/03/190313143248.htm
Comments
Post a Comment
Thank you for your message. We are improving our services everyday.